Amphastar Pharmaceuticals AMPH Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's current ratio?
- Amphastar Pharmaceuticals (AMPH) reported current ratio of 3.9× in Q1 2026.
- How has Amphastar Pharmaceuticals's current ratio changed year-over-year?
- Amphastar Pharmaceuticals's current ratio increased by 30.4% year-over-year, from 3× to 3.9×.
- What is the long-term trend for Amphastar Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's current ratio has grown at a 10.0% compound annual growth rate (CAGR), from 2.5× to 4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.